4.7 Article

Cyclin-dependent kinase 9-cyclin K functions in the replication stress response

Journal

EMBO REPORTS
Volume 11, Issue 11, Pages 876-882

Publisher

WILEY
DOI: 10.1038/embor.2010.153

Keywords

CDK9; cyclin K; DNA replication; DNA damage response; checkpoint

Funding

  1. National Cancer Institute [R01CA136933]
  2. Vanderbilt Center in Molecular Toxicology [P30ES000267]
  3. Vanderbilt-Ingram Cancer Center
  4. Vanderbilt Institute for Clinical and Translational Research [UL1 024975]
  5. Department of Defense [BC085283]
  6. American Board of Radiology

Ask authors/readers for more resources

Cyclin-dependent kinase 9 (CDK9) is a well-characterized subunit of the positive transcription elongation factor b complex in which it regulates transcription elongation in cooperation with cyclin T. However, CDK9 also forms a complex with cyclin K, the function of which is less clear. Using a synthetic lethal RNA interference screen in human cells, we identified CDK9 as a component of the replication stress response. Loss of CDK9 activity causes an increase in spontaneous levels of DNA damage signalling in replicating cells and a decreased ability to recover from a transient replication arrest. This activity is restricted to CDK9-cyclin K complexes and is independent of CDK9-cyclin T complex. CDK9 accumulates on chromatin in response to replication stress and limits the amount of single-stranded DNA in cells under stress. Furthermore, we show that CDK9 and cyclin K interact with ataxia telangiectasia and Rad3-related protein and other checkpoint signalling proteins. These results reveal an unexpectedly direct role for CDK9-cyclin K in checkpoint pathways that maintain genome integrity in response to replication stress.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available